1. Home
  2. STOK vs RAMP Comparison

STOK vs RAMP Comparison

Compare STOK & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.65

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$28.78

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
RAMP
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2019
1987

Fundamental Metrics

Financial Performance
Metric
STOK
RAMP
Price
$30.65
$28.78
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$31.00
$40.17
AVG Volume (30 Days)
1.2M
643.1K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
1315.78
EPS
0.68
0.61
Revenue
$205,632,000.00
$778,787,000.00
Revenue This Year
$416.54
$10.65
Revenue Next Year
N/A
$8.47
P/E Ratio
$45.14
$49.54
Revenue Growth
1128.17
10.13
52 Week Low
$5.35
$22.82
52 Week High
$38.69
$36.08

Technical Indicators

Market Signals
Indicator
STOK
RAMP
Relative Strength Index (RSI) 60.05 50.21
Support Level $28.51 $27.91
Resistance Level $29.38 $29.72
Average True Range (ATR) 1.99 0.86
MACD 0.55 -0.09
Stochastic Oscillator 93.67 23.42

Price Performance

Historical Comparison
STOK
RAMP

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

Share on Social Networks: